For years, feline infectious peritonitis (FIP) was considered an almost universally fatal disease. When research identified a highly effective antiviral but no legal US treatment became available, desperate owners, rescue workers, and veterinarians turned to encrypted messages, Facebook groups, and overseas suppliers. Their improvised network saved countless cats—but also created serious safety, legal, and ethical problems.
Key takeaways
- FIP, a coronavirus-related disease, historically killed nearly every cat that developed it.
- The antiviral GS-441524 was found to cure roughly 90% or more of treated cats in research.
- A global black market emerged because the drug was not legally available through US veterinary channels.
- Investigators uncovered millions of dollars in sales and significant undisclosed profits.
- Compounding pharmacies began making the treatment available legally in the US in 2024.
A devastating diagnosis
Marlena Arjo learned how frightening FIP can be after her young cat, Otto, stopped eating and developed neurological symptoms. A veterinarian told her the clinic had little to offer, then quietly directed her to a Facebook group where owners shared information about an unapproved treatment.
FIP commonly affects young cats and can damage multiple organs. Symptoms such as appetite loss, lethargy, fluid buildup, fever, and neurological changes require prompt veterinary attention. Although stress can also cause cats to hide or refuse food, PAWSONA emphasizes that sudden or severe symptoms should never be treated as a behaviour problem alone. Calming products may support a stressed cat’s environment, but they cannot treat FIP or other serious illnesses.
Research opened the door—and left a gap
UC Davis veterinary researcher Niels Pedersen spent decades studying FIP and helped establish that the disease results when a normally mild feline coronavirus mutates inside some cats. His team found that GS-441524 could stop the virus and cure most treated cats.
The compound was related to remdesivir, an antiviral developed by Gilead Sciences for human diseases. But Gilead did not pursue approval for the feline version. The company cited its focus on human medicine and concerns surrounding the approval process. With the patent still in force and no approved veterinary product available, owners were left with a treatment that existed scientifically but not practically.
Facebook groups became an international supply chain
Groups such as FIP Warriors connected owners with overseas manufacturers, treatment guidance, and volunteer administrators. Members collected medical information, arranged shipments, and monitored cats through lengthy treatment courses. Some veterinarians reportedly referred owners to these networks while avoiding direct involvement that could threaten their licenses.
The system was risky. Product quality varied, shipments were intercepted, and at least one brand reportedly failed to work. Some administrators also received commissions or marked up medications, despite public claims that the group did not profit. The investigation found that Nicole Randall sold more than $9.5 million worth of GS and earned about $4 million. She later pleaded guilty to introducing an adulterated, unapproved drug into interstate commerce and surrendered assets purchased with the proceeds.
Advocacy helped move treatment into pharmacies
After internal disputes and the raid, former administrators pushed for a legal alternative. They focused on federal rules allowing veterinarians to prescribe compounded medications when no suitable approved treatment exists.
In June 2024, Stokes Pharmacy began compounding GS-441524, followed by other pharmacies. The change did not erase the black market overnight, partly because information remained uneven among veterinarians and cat owners. However, it gave families a regulated path to treatment and reduced reliance on anonymous sellers.
What cat owners should do
FIP remains a medical emergency, not a condition to diagnose through social media. Owners should seek a veterinarian promptly when a cat stops eating, loses weight, becomes unusually tired, develops persistent fever, or shows abdominal, eye, or neurological changes. Ask about current legal treatment options and use medication only under professional guidance.
For cats experiencing ordinary environmental stress—such as moving, introducing another pet, or visiting the veterinarian—predictable routines, safe hiding spaces, gradual introductions, and evidence-informed calming support can help. PAWSONA’s approach begins with understanding the cause of a cat’s distress while keeping medical concerns in the hands of qualified veterinary professionals.
The FIP drug saga ultimately exposed both the power of grassroots animal advocacy and the dangers created when medical breakthroughs remain inaccessible. A treatment that once required clandestine networks is now increasingly available through legitimate veterinary channels, offering owners a safer way to protect vulnerable cats.
- The Black Market for a Lifesaving Cat Drug, Reveal from The Center for Investigative Reporting.
- The Black Market for a Lifesaving Cat Drug – Mother Jones, Mother Jones.